RNA Interference (RNAi) has become a widespread technology in the life sciences industry and the extent of promising research in ongoing programs has a huge potential in the future. RNAi has great scope in diverse areas including drug discovery, drug development, therapeutic applications, and basic research. Thus, RNAi market has enormous opportunities in the scientific industry, says our new research report, “Global RNAi Market Analysis”.
Our research identified that, amongst the various segments in the RNAi market, the largest is attributed to Nanoparticle RNAi delivery. Also it was found that the future is very promising for RNAi delivery through Nucleic Acid and Aptamer and these sectors are to experience substantial growth in the coming years. Backed by innovation, the global RNAi market estimated to grow at a CAGR of around 28% during 2010-2015.
The number of industrial sectors employing these RNAi technologies is increasing as indicated by the increased use in functional genomics, disease diagnostics, and agriculture, amongst others. Research has been extensive in the field however there is scope for further development for RNAi to stand the strictness of delivery for therapeutic advantage.
Our report , “Global RNAi Market Analysis”, provides an overview of the RNAi market. It also presents a market overview of the RNAi-based drug delivery along with the various technologies covered in it. The report summarizes several applications for which, RNAi is primarily used and also covers latest trends prevalent in the industry. A detailed listing of RNAi-based products by type has been provided that helps the reader to understand the overall market demand. Further, a geographical segmentation of the major countries is provided along with coverage on recent developments in each of the areas. Finally, competitive landscape on the leading competitors in the industry has been presented in our report to provide our readers with a holistic view of the sector and take an informed investment decision.
For more Information visit: http://www.rncos.com/Report/IM329.htm |
